Dampening IL6 is a potential therapeutic avenue for immuno-modulation because IL6 is elevated in patients suffering from ARDS and its level correlated positively with viral loads (del Valle et al., 2020). This evidence concerns the gene IL6 and acute respiratory distress syndrome.